Skip to main content
SpringerLink
Log in

Mineral Metabolism

  • Chapter
Contemporary Nephrology

Abstract

The vitamin D endocrine system utilizes metabolites of vitamin D in the regulation of a wide variety of metabolic processes.1 Calcitriol (1,25-dihydroxy vitamin D) is the most biologically active metabolite, and this compound functions as an important steroidal hormone.2

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bell, N. H., 1985, Vitamin D-endocrine system, J. Clin. Invest. 76: 1 6.

    PubMed  CAS  Google Scholar 

  2. Norman, A. W., Roth, J., and Orci, L., 1982, The vitamin D endocrine system: Steroid metabolism, hormone receptors and biological response (calcium binding proteins), Endocr. Rev. 3: 331 366.

    PubMed  CAS  Google Scholar 

  3. Holick, M. F., McLaughlin, J. A., Clark, M. B., Holick, S. C., Potts, J. T., Jr., Anderson, R. R., Blank, I. H., Parrish, J. A., and Elias, P., 1980, Photosynthesis of previtamin D3 in human skin and the physiologic consequences, Science 210: 203 205.

    PubMed  CAS  Google Scholar 

  4. Fraser, D. R., 1983, The physiological economy of vitamin D, Lancet 1: 969 972.

    PubMed  CAS  Google Scholar 

  5. Newton, H. M. V., Sheltawy, M., Hay, A. W. M., and Morgan, B., 1985, The relations between vitamin D2 and D3 in the chick plasma 25(OH)2D2 and 25(OH)2D3 in elderly women in Great Britain, Am. J. Clin. Nutr. 41: 760 764.

    PubMed  CAS  Google Scholar 

  6. MacLaughlin J. and Holick, M. F., 1985, Aging decreases the capacity of human skin to produce vitamin D3, J. Clin. Invest. 76: 1536 1538.

    PubMed  CAS  Google Scholar 

  7. Bell, N. M., Greene, A., Epstein, S., Oexmann, M. J., Shaw, S., and Shary, J., 1985, Evidence for alteration of vitamin D-endocrine system in blacks, J. Clin. Invest. 76: 470 473.

    PubMed  CAS  Google Scholar 

  8. Cooke, N. E., and David, E. V., 1985, Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family, J. Clin. Invest. 76: 2420 2424.

    PubMed  CAS  Google Scholar 

  9. Bikle, D. D., Siiteri, P. K., Ryzen, E., and Haddad, J. G., 1985, Serum protein binding of 1,25-dihydroxyvitamin D: A reevaluation by direct measurement of free metabolite levels, J. Clin. Endocrinol. Metab. 61: 969 975.

    PubMed  CAS  Google Scholar 

  10. Bell, N. H., Shaw, S., and Turner, R. T., 1984, Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxy vitamin D in man, J. Clin. Invest. 74: 1540 1544.

    PubMed  CAS  Google Scholar 

  11. Audran, M., Gross, M., and Kumar, R., 1986, The physiology of the vitamin D endocrine system, Semin. Nephrol. 6: 4 20.

    PubMed  CAS  Google Scholar 

  12. Kawashima, H. and Kurokawa, K., 1986, Metabolism and sites of action of vitamin D in the kidney, Kidney Int. 29: 98 107.

    PubMed  CAS  Google Scholar 

  13. Lemann, J. Jr., Gray, R. W., and Korkor, A. B., 1984, Vitamin D and kidney disease, in: Nephrology, Volume II ( R. R. Robinson, ed.), SpringerVerlag, New York, pp. 1304 1321.

    Google Scholar 

  14. Caldas, A. E., Gray, R. W., and Lemann, J., Jr., 1978, The simultaneous measurement of vitamin D metabolites in plasma: Studies in healthy adults and in patients with nephrolithiasis, J. Lab. Clin. Med. 91: 840 849.

    PubMed  CAS  Google Scholar 

  15. van Dieman-Steenvoorde, R., Donckerwolcke, R. A., Bosch, R., Visser, W. J., Raymakers, J. A., and Duursma, S. A., 1985, Treatment of renal osteodystrophy in children with dihydrotachysterol and 24,25 dihydroxy vitamin D3, Clin. Neprhol. 24: 292 299.

    Google Scholar 

  16. Avioli, L. V. and Haddad, J. G., 1984, The vitamin D family revisited, N. Engl. J. Med. 311: 47 49.

    PubMed  CAS  Google Scholar 

  17. Halloran, B. P., Portale, A. A., Castro, M., Morris, R. C. Jr., and Goldsmith, R. S., 1985, Serum concentration of 1,25-dihydroxy vitamin D in the human: Diurnal variation, J. Clin. Endocrinol. Metabol. 60: 1104 1110.

    CAS  Google Scholar 

  18. Stern, P. H., Taylor, A. B., Bell, N. H., and Epstein, S., 1981, Demonstration that circulation 1 a-25-dihydroxyvitamin is loosely regulated in normal children, J. Clin. Invest. 68: 1374 1377.

    PubMed  CAS  Google Scholar 

  19. Booth, B. E., Tsai, H. C., and Morris, R. C. Jr., 1985, Vitamin D status regulates 25-hydroxyvitamin D3-l a-hydroxylase and its responsiveness to parathyroid hormone in the chick, J. Clin. Invest. 75: 155 161.

    PubMed  CAS  Google Scholar 

  20. Mayer, E., Bishop, J. E., Chandraranta, A. S., Okamura, W. H., Kruse, J. J., Popjak, G., Ohnuma, N., and Norman, A. W., 1983, Isolation and identification of l,25-dihydroxy-24-oxo-vitamin D3 and 1,23,25 trihydroxy-24-oxo-vitamin D3, J. Biol. Chem. 258: 13458 13465.

    PubMed  CAS  Google Scholar 

  21. Lund, B. J., Sørensen, O. H., Lund, B. I., Bishop, J. E., and Norman, A. W., 1980, Vitamin D metabolism in hypoparathyroidism, J. Clin. Endocr. Metab. 51: 606 510.

    PubMed  CAS  Google Scholar 

  22. Henry, H. L., 1985, Parathyroid hormone modulation of 25-hydroxy vitamin D3 metabolism by cultured chick kidney cells is mimicked and enhanced by forskolin, Endocrinology 116: 503 510.

    PubMed  CAS  Google Scholar 

  23. LoCasio, V., Adami, S., Galvanini, G., Ferrari, M., Cominacini, L., and Tartarotti, B. S., 1985, Substrate-product relationship of 1-hydroxylase activity in primary hyperparathyroidism, N. Engl. J. Med. 313: 1123 1125.

    Google Scholar 

  24. Bell, N. H., Epstein, S., Greene, A., Shary, J., Oexmann, M. J., and Shaw, S., 1985, Evidence for alteration of the vitamin D-endocrine system in obese subjects, J. Clin. Invest. 76: 370 373.

    PubMed  CAS  Google Scholar 

  25. Kawashima, H., Torikai, S., and Kurokawa, K., 1981, Calcitonin selectively stimulates 25-hydroxyvitamin D3-I a-hydroxylase in the proximal straight tubule of the kidney, Nature 291: 327 329.

    PubMed  CAS  Google Scholar 

  26. Bushinsky, D. A., Riera, G. S., Favus, M. J., Coe F. L., 1985, Evidence that blood ionized calcium can regulate serum l,25(OH)2D3 independently of parathyroid hormone and phosphorus in the rat, J. Clin. Invest. 76: 1599 1604.

    PubMed  CAS  Google Scholar 

  27. Hulter, H. N., Halloran, B. P., Toto, R. D., and Peterson, J. C., 1985, Longterm control of plasma calcitriol concentration in dogs and humans. Dominant role of experimental hyperparathyroidism, J. Clin. Invest. 76: 695 702.

    PubMed  CAS  Google Scholar 

  28. Gray, R. W. and Garthwaite, T. L., 1985, Activation of renal 1,25 dihy-droxyvitamin D3 synthesis by phosphate deprivation: Evidence for a role for growth hormone, Endocrinology 116: 189 193.

    PubMed  CAS  Google Scholar 

  29. Portale, A. A., Halloran, B. P., Murphy, M. M., and Morris, C. R. Jr., 1986, Oral intake of phosphorus can determine the serum concentration of 1,25dihydroxy vitamin D by determining its production rate in humans, J. Clin. Invest. 77: 7 12.

    PubMed  CAS  Google Scholar 

  30. Brunette, M. G., 1985, The X-linked hypophosphatemic vitamin D resistant rickets: Old and new concepts, Int. J. Pediatr. Nephrol. 6: 55 62.

    PubMed  CAS  Google Scholar 

  31. Prince, M. J., Schaefer, P. C., Goldsmith, R. S., and Chausmer, A. B., 1982, Hyperphosphatemic tumoral calcinosis, Ann. Intern. Med. 96: 586 591.

    PubMed  CAS  Google Scholar 

  32. Rude, R. K., Adams, J. S., Ryzen, E., Endres, D. B., Niimi, H., Horst, R. L., Haddad, J. G., and Singer, F. R., 1985, Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency, J. Clin. Endocr. Metab. 61: 933 940.

    PubMed  CAS  Google Scholar 

  33. Barbour, G. L., Coburn, J. W., Slatopolsky, E., Norman, A. W., and Horst, R. L., 1981, Hypercalcemia in an anephric patient with sarcoidosis: Evidence for extrarenal generation of 1,25-dihydroxy vitamin D, N. Engl. J. Med. 305: 440 443.

    PubMed  CAS  Google Scholar 

  34. Gkonos, P. J., London, R., and Hendler, E. D., 1984, Hypercalcemia and elevated 1,25-dihydroxy vitamin D levels in a patient with end stage renal disease and active tuberculosis, N. Engl. J. Med. 311: 1683 1685.

    PubMed  CAS  Google Scholar 

  35. Rosenthal, N., Insogna, K. L., Godsall, J. W., Smaldone, L., Waldron, J. A., and Stewart, A. F., 1985, Elevations of circulating 1,25-dihydroxyvitamin D in three patients with lymphoma associated with hypercalcemia, J. Clin. Endocr. Metab. 60: 29 33.

    PubMed  CAS  Google Scholar 

  36. Halloran, B. P., Schaefer, P., Lifschitz, M., Levens, M., and Goldsmith, R. S., 1984, Plasma vitamin D metabolite concentration in chronic renal fail ure: Effect of oral administration of 25-hydroxyvitamin D3, J. Clin. Endocr. Metab. 59: 1063 1069.

    PubMed  CAS  Google Scholar 

  37. Devlin, E. E., Arabian, A., Gloreiux, F., and Mamer, O. A., 1985, In vitro metabolism of 25-hydroxycholecalciferol by isolated cells from human deciduaj. Clin. Endocr. Metab. 60: 880 885.

    Google Scholar 

  38. Zerwekh, J. E. and Breslau, N. A., 1986, Human placental production of 1 a,25-dihydroxyvitamin D3: Biochemical characterization and production in normal subjects and patients with pseudohypoparathyroidism, J. Clin. Endocr. Metab. 62: 192 196.

    PubMed  CAS  Google Scholar 

  39. Braidman, I. P. and Anderson, D. C., 1985, Extra-endocrine functions of vitamin D, Clin. Endocr. 23: 445 460.

    PubMed  CAS  Google Scholar 

  40. Haussler, M. R., Donaldson, C. A., Kelly, M. A., Mangelsdorf, D. J., Marion, S. L., and Pike, J. W., 1985, Functions and mechanism of action of the 1,25-dihydroxyvitamin D3 receptor, in: Vitamin D, Chemical, Biochemical and Clinical Update (A. W. Norman, K. Schaefer, H-G. Grigoleit, and D. V. Herrath, eds.), de Gruyter, Berlin, pp. 83 92.

    Google Scholar 

  41. Sher, E., Frampton, R. J., and Eisman, J. A., 1985, Regulation of the 1,25dihydroxyvitamin D3 receptor by 1,25-dihydroxyvitamin D3 in intact human cancer cells, Endocrinology 116: 971 977.

    PubMed  CAS  Google Scholar 

  42. Adams, J. S., Gacad, M. A., Baker, A. J., Kheun, G., and Rude, R. K., 1985, Diminished internalization and action of 1,25-dihydroxy vitamin D3 in dermal fibroblasts cultured from New World primates, Endocrinology 116: 2523 2527.

    PubMed  CAS  Google Scholar 

  43. Koren, R., Ravid, A., Liberman, U. A., Hochberg, Z., Weisman, Y., and Novogrodsky, A., 1985, Defective binding and functions of 1,25-dihydroxy vitamin D3 receptors in peripheral mononuclear cells of patients with endorgan resistance to 1,25-dihydroxy vitamin D, J. Clin Invest. 76: 2012 2015.

    PubMed  CAS  Google Scholar 

  44. Hirst, M. A., Hochman, H. I., and Feldman, D., 1985, Vitamin D resistance and alopecia: A kindred with normal 1,25-dihydroxy vitamin D binding, but decreased receptor affinity for deoxyribonucleic acid, Clin. Endocr. Metab. 60: 490 495.

    CAS  Google Scholar 

  45. Nemere, I., Yoshimoto, Y., and Norman, A. W., 1981, Calcium transport in perfused duodena from normal chicks: Enhancement within fourteen minutes of exposure to 1,25-dihydroxy vitamin D3, Endocrinology 115: 1476 1483.

    Google Scholar 

  46. Bikle, D. D., Whitney, J., and Munson, S., 1984, The relationship of membrane fluidity to calcium flux in chick intestinal brush border membranes, Endocrinology 114: 260 267.

    PubMed  CAS  Google Scholar 

  47. Bikle, D. D. and Munson, S., 1985, 1,25-dihydroxyvitamin D increases calmodulin binding to specific proteins in the chicks duodenal brush border membrane, J. Clin Invest. 76: 2312 2316.

    Google Scholar 

  48. Shedl, H. P., Miller, D. L., Pape, J. M., Horst, R. L., and Wilson, H. D., 1984, Calcium and sodium transport and vitamin D metabolism in the spontaneously hypertensive rat, J. Clin Invest. 73: 980 986.

    Google Scholar 

  49. Korkor, A. B., Kuchibotla, J., Arrieh, M., Gray, R. W., and Gleason, W. A., Jr., 1985, The effects of chronic prednisone administration on intestinal receptors for 1,25-dihydroxyvitamin D3 in the dog, Endocrinology 117: 2267 2273.

    PubMed  CAS  Google Scholar 

  50. Karsenty, G., Lacour, B., Ulmann, A., Pierandrei, E., and Drueke, J., 1985, Early effects of vitamin D metabolites on phosphate fluxes in isolated rat enterocytes, Am. J. Physiol. 248: 640 645.

    Google Scholar 

  51. Kurihara, N., Ishizuka, S., Kiyoki, M., Haketa, Y., Ikeda, K., and Kumegawa, M., 1986, Effects of 1,25-dihydroxyvitamin D3 on osteoclastic MC 3T3-E 1 cells, Endocrinology 118: 940 947.

    PubMed  CAS  Google Scholar 

  52. Holtrop, M. E., Cox, K. A., Clarke, M. B., Holick, M. F., and Anast, C. S., 1981, 1,25-dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone, Endocrinology 108: 2293 2301.

    Google Scholar 

  53. Key, L., Carnes, D., Cole, S., Holtrop, M., Bar-Shavit, Z., Shapiro, F., Arceci, R., Steinberg, J., Gundberg, C., Kahn, A., Teitelbaum, S., and Anast, C., 1984, Treatment of congenital osteopetrosis with high dose calcitriol, N. Engl. J. Med. 310: 409 415.

    PubMed  CAS  Google Scholar 

  54. Chen, T. L., Hauschka, P. V., Cabrales, S., and Feldman, D., 1986, The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast like primary cell cultures: Expression patterns for three different bioresponses, Endocrinology 118: 250 259.

    PubMed  CAS  Google Scholar 

  55. Silve, C., Grosse, B., Tau, C., Garabedian, M., Futsch, J., Delmas, P. D., Cournot-Witmer, G., and Balsam, S., 1986, Response to parathyroid hormone and 1,25-dihydroxyvitamin D3 of bone-derived cells isolated from normal children with abnormalities in skeletal development, J. Clin. Endocr. Metab. 62: 583 590.

    PubMed  CAS  Google Scholar 

  56. Yamamoto, M., Kawanobe, Y., Takahashi, H., Shimazawa, E., Kimura, S., and Ogata, E., 1984, Vitamin D deficiency and renal calcium transport in the rat, J. Clin. Invest. 74: 507 513.

    PubMed  CAS  Google Scholar 

  57. Roth, J., Brown, D., Norman, A. W., and Orci, L., 1982, Localization of the vitamin D calcium-binding protein in mammalian kidney, Am. J. Physiol. 243: F243 F252.

    PubMed  CAS  Google Scholar 

  58. Liang, T. C., Barnes, J., Balakir, R., Cheng, L., and Sacktor, B., 1982, In vitro stimulation of phosphate in isolated chick renal cells by 1,25-dihydroxycholecalciferol, Proc. Natl. Acad. Sci. USA 79: 3532 3536.

    PubMed  CAS  Google Scholar 

  59. Kurnik, B. R. C. and Hruska, K. A., 1984, Effect of 1,25-dihydroxycholecalciferol on phosphate transport in vitamin D-deprived rats, Am. J. Physiol. 247: F177 F182.

    PubMed  CAS  Google Scholar 

  60. Egel, J., Pfanstiel, J., and Puschett, J. B., 1985, Effects of 1,25-dihydroxyvitamin D3 on membrane transport and intermediary metabolism, Miner. Electrolyte Metab. 11: 62 68.

    PubMed  CAS  Google Scholar 

  61. Hochberg, Z., Borochowitz, Z., Benderli, A., Vardi, P., Oren, S., Spirer, Z., Hayman, I., and Weisman, Y., 1985, Does 1,25-dihydroxy vitamin D participate in the regulation of hormone release from the endocrine glands? J. Clin. Endocr. Metab. 60: 57 61.

    PubMed  CAS  Google Scholar 

  62. Kadowaki, S. and Norman, A. W., 1985, Time course study of insulin secretion after 1,25-dihydroxyvitamin D3 administration, Endocrinology 117: 1765 1771.

    PubMed  CAS  Google Scholar 

  63. Akmal, M., Massry, S. G., Goldstein, D. A., Fanti, P., Weisz, A., and DeFronzo, R. A., 1985, Role of parathyroid hormone in glucose intolerance of chronic renal failure, J. Clin Invest. 75: 1037 1044.

    PubMed  CAS  Google Scholar 

  64. Mak, R. H. K., Bettinelli, A., Turner, C., Haycock, G. B., and Chantler, C. 1985, The influence of hyperparathyroidism on glucose metabolism in uremia, J. Clin. Endocr. Metab. 60: 229 233.

    PubMed  CAS  Google Scholar 

  65. Cantley, L. K., Russell, J., Lettieri, D., and Sherwood, L. M., 1985, 1,25dihydroxyvitamin D3 suppresses parathyroid hormone secretion in bovine parathyroid cells in tissue culture, Endocrinology 117: 2114 2119.

    Google Scholar 

  66. Seshadri, M. S., Frankel, T. L., Lissner, D., Mason, R. S., and Posen, S., 1985, Bioactive parathyroid hormone in the rat: Effects of calcium and calcitriol, Endocrinology 117: 2417 2423.

    PubMed  CAS  Google Scholar 

  67. Slatopolsky, E., Weerts, C., Thielan, J., Horst, R., Harter, H., and Martin, K. J., 1984, Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy cholecalciferol in uremic patients, J. Clin. Invest. 74: 2136 2143.

    PubMed  CAS  Google Scholar 

  68. Reichel, H., Koeffler, H. P., Barbers, R., Munker, R., and Norman, A. W., 1985, 1,25-dihydroxyvitamin D3 and the hematopoetic system, in: Vitamin D. Chemical, Biochemical and Clinical Update (A. W. Norman, K. Shaefer, HG. Grigoleit, and D. V. Herrath, eds.), de Gruyter, Berlin, pp. 167 176.

    Google Scholar 

  69. Adams, J. S., Singer, F. R., Gacad, M. A., Sharma, O P., Hayes, M. J., Vouros, P., and Holick, M. F., 1985, Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis, J. Clin. Endocr. Metab. 60: 960 966.

    PubMed  CAS  Google Scholar 

  70. Manolagas, S. C., 1985, Role of 1,25-dihydroxyvitamin D3 in the immune system, in: Vitamin D, Chemical, Biochemical and Clinical Update (A. W. Norman, K. Shaefer, H-G. Grigoleit, and D. V. Herrath, eds.), de Gruyter, Berlin, pp. 199 208.

    Google Scholar 

  71. Sherrard, D. J., Ott, S. M., Andress, D. L., and Coburn, J. W., 1985, Histologic response to 24,25(OH)2 vitamin D in renal osteodystrophy, in: Vitamin D, Chemical, Biochemical and Clinical Update (A. W. Norman, K. Shaefer, H-G. Grigoleit, and D. V. Herrath, eds.), de Gruyter, Berlin, pp. 269 273.

    Google Scholar 

  72. Horst, R. L., Littledike, E. T., Gray, R. W., and Napoli, J. L., 1981, Impaired 24,25-dihydroxyvitamin D production in anephric human and pig, J. Clin. Invest. 67: 274 280.

    PubMed  CAS  Google Scholar 

  73. Olgaard, K., Finco, D., Schwartz, J., Arbelaez, M., Teitelbaum, S., Avioli, L., Klahr, S., and Slatopolsky, E., 1984, Effect of 24,25(OH)2D3 on PTH levels and bone histology in dogs with chronic uremia, Kidney Int. 26: 791 797.

    PubMed  CAS  Google Scholar 

  74. Canterbury, J. M., Gavellas, G., Bourgoignie, J. J., and Reiss, E., 1980, Metabolic consequences of oral administration of 24,25-dihydroxycholecalciferol to uremic dogs, J. Clin Invest. 65: 571 576.

    PubMed  CAS  Google Scholar 

  75. Friedlander, M. A., Horst, R. L., and Hawker, C. D., 1984, Absence of effect of 24,25-dihydroxycholecalciferol on serum immuno reactive PTH in patients with persistant hyperparathyroidism after renal transplantation, Clin. Nephrol. 22: 206 210.

    PubMed  CAS  Google Scholar 

  76. Asscheman, H., Netelenbos,J. C., Lips, P., van der Vijgh, W.J. F.,Johgen, M. J. M., van Ginkel, F., and Hacking, W. H. L., 1985, Effect of 24,25dihydroxyvitamin D3 on parathyroid function in: Vitamin D, Chemical, Biochemical and Clinical Update (A. W. Norman, K. Shaefer, H-G. Grigoleit, and D. V. Herrath, eds.), de Gruyter, Berlin, pp. 306 307.

    Google Scholar 

  77. Parfitt, A. M., Matthews, C. H. E., Brommage, R., Jarnagin, K., and DeLuca, H. F., 1984, Calcitriol but no other metabolite of vitamin D is essential for normal bone growth and development in the rat, J. Clin. Invest. 73: 576 586.

    PubMed  CAS  Google Scholar 

  78. Rambeck, W. A., Goralczyk, R., Troger, C., and Zucker, H., 1985, Synergistic effects of l,25(OH)2D3 and 24,25(OH)2D3 in rachitic chicks, in: Vitamin D, Chemical, Biochemical and Clinical Update (A. W. Norman, K. Shaefer, H-G. Grigoleit, and D. V. Herrath, eds.), de Gruyter, Berlin, pp. 298 299.

    Google Scholar 

  79. Somjen, D., Weisman, Y., Berger, E., Fine, N., Kaye, A. M., and Binderman, I., 1985, A comparison of the responses to 24R, 25(OH)2D3 and I, 25(OH)2D3 by developing skeletal tissue in: Vitamin D, Chemical, Biochemical and Clinical Update (A. W. Norman, K. Shaefer, H-G. Grigoleit, and D. V. Herrath, eds.), de Gruyter, Berlin, pp. 284 293.

    Google Scholar 

  80. Potts, J. T. Jr., Kronenberg, H. M., and Rosenblatt, M., 1982, Parathyroid hormone: Chemistry, biosynthesis and mode of action, Adv. Protein Chem. 35: 323 396.

    PubMed  CAS  Google Scholar 

  81. Kronenberg, H. M., Hellerman, J. G., Born, W. J., Mulligan, R. C., Freeman, M. W., Rich, A., and Potts, J. T. Jr., 1984, Studies of parathyroid hormone secretion using recombinant DNA technology, in: Endocrine Control of Bone and Calcium Metabolism, Volume 8A ( D. V. Cohn, T. Fujita, J. T. Potts, Jr., and R. V. Talmage, eds.), Elsevier, Amsterdam, pp. 217 220.

    Google Scholar 

  82. Hellerman, J. G., Care, R. C., Potts, J. T. Jr., Mulligan, R. C., and Kronenberg, H. M., 1984, Secretion of human parathyroid hormone from rat pituitary cells infected with a recombinant retrovirus encoding preparathyroid hormone, Proc. Natl. Acad. Sci. USA 81: 5340 5344.

    PubMed  CAS  Google Scholar 

  83. Rabbani, S. A., Kremer, R., Bennett, H. P. T., and Goltzman, D., 1984, Phosphorylation of parathyroid hormone by human and bovine parathyroid glands, J. Biol. Chem. 259: 2949 2955.

    PubMed  CAS  Google Scholar 

  84. Kemper, B., Habener, J. F., and Potts, J. T. Jr., 1974, Parathyroid secretion: Discovery of a major calcium dependent protein, Science 184: 167 169.

    PubMed  CAS  Google Scholar 

  85. Bhargava, G., Russell, J., and Sherwood, L. M., 1983, Phosphorylation of parathyroid secretory protein, Proc. Natl. Acad. Sci. USA 80: 878 881.

    PubMed  CAS  Google Scholar 

  86. O’Connor, D., Burton, D., and Deftos, L., 1984, Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues, J. Clin. Endocr. Metab. 57: 1084 1086.

    Google Scholar 

  87. Brown, E. M., Gardner, D. J., Brennan, M. F., Marx, S. J., Spiegel, A. M., Attie, M F., Downs, R. W., Doppmann, J. L., and Aurbach, G. D., 1979, Calcium-regulated parathyroid hormone release in primary hyperparathyroidism. Studies in vitro with dispersed parathyroid cells, Am. J. Med. 66: 923 931.

    PubMed  CAS  Google Scholar 

  88. Dietel, M., Arps, H., Schafer, H-J., and Holzel, F., 1984, Ultracytochemical demonstration of the calcium distribution in normal and adenomatous parathyroid cells influenced by calcium and non-calcium regulators in vitro, in: Endocrine Control of Bone and Calcium Metabolism, Volume 8A ( D. V. Cohn, T. Fujita, J. T. Potts, Jr., and R. V. Talmage, eds.), Elsevier, Amsterdam, pp. 221 225.

    Google Scholar 

  89. LeBoff, M. S., Rennke, G., and Brown, E. M., 1983, Abnormal regulation of parathyroid cell secretion and proliferation in primary cultures of bovine parathyroid cells, Endocrinology 113: 277 284.

    PubMed  CAS  Google Scholar 

  90. Shoback, D. M., Thatcher, J., Leombruno, R., and Brown, E. M., 1984, Relationship between TPH secretion and cytosolic calcium concentration in dispersed bovine parathyroid cells, Proc. Natl. Acad. Sci. USA 81: 3113 3117.

    PubMed  CAS  Google Scholar 

  91. LeBoff, M. S., Shoback, D. M., Brown, E. M., Thatcher, J., Leombruno, R., Beaudoin, D., Henry, M., Wilson, R., Pallota, J., Marynick, S., Stock, J., and Leight, G., 1985, Regulation of parathyroid hormone release and cytosolic calcium by extracellular calcium in dispersed and cultured bovine and pathological human parathyroid cells, J. Clin Invest. 75: 49 57.

    PubMed  CAS  Google Scholar 

  92. Parfitt, A. M., 1969, Relation between parathyroid cell mass and plasma calcium concentration in normal and uremic subjects, Arch. Intern. Med. 124: 269 273.

    PubMed  CAS  Google Scholar 

  93. Oldham, S. B., Molloy, C. T., and Lipson, L. G., 1984, Calcium inhibition of parathyroid adenyl cyclase, Endocrinology 114: 207 213.

    PubMed  CAS  Google Scholar 

  94. Fischer, J. A., and Blum, J. W., 1980, Non-calcium control of parathyroid hormone secretion, Miner. Electrolyte Metab. 3: 158 162.

    CAS  Google Scholar 

  95. Brown, E. M., and Aurbach, G. D., 1981, Role of cyclic nucleotides in secretory mechanisms and actions of parathyroid hormone and calcitonin, Vitam. Horm. 38: 205 210.

    CAS  Google Scholar 

  96. Estep, H., Shaw, W. A., Watlington, C., Hobe, R., Holland, W., Tucker, S. G., 1969, Hypocalcemia due to hypomagnesemia and reversible parathyroid hormone unresponsiveness, J. Clin. Endocr. Metab. 29: 842 848.

    CAS  Google Scholar 

  97. Rude, R. K., Oldham, S. B., Sharp, C. F. Jr., and Singer, F. R., 1978, Parathyroid hormone secretion in magnesium deficiency, J. Clin. Endocr. Metab. 47: 800 806.

    PubMed  CAS  Google Scholar 

  98. Habener, J. F., and Potts, J. T., Jr., 1976, Relative effectiveness of magnesium and calcium on the secretion and biosynthesis of parathyroid hormone in vitro, Endocrinology 98: 197 202

    CAS  Google Scholar 

  99. Cholst, I. N., Steinberg, S. F., Tropper, P. J., Fox, H. E., Segre, G. V., and Bilezikian, J. P., 1984, The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects, N. Engl. J. Med. 310: 1221 1225.

    PubMed  CAS  Google Scholar 

  100. Hodsman, A. B., Sherrard, D. J., Alfrey, A. C., Oh, S., Brickman, A. S., Miller, N. L., Moloney, N. A., and Coburn, J. W., 1982, Bone aluminum and histomorphometric features of renal osteodystrophy, J. Clin. Endocr. Metab. 54: 539 546.

    PubMed  CAS  Google Scholar 

  101. Kraut, J. A., Shinaberger, J. H., Singer, F. R., Sherrard, D. J., Saxton, J., Miller, J. H., Kurokawa, K., and Coburn, J. W., 1983, Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia, Kidney Int. 23: 725 730.

    PubMed  CAS  Google Scholar 

  102. Andress, D., Felsenfield, A. J., Voigts, A., and Llach, F., 1983, Parathyroid hormone responsiveness to hypocalcemia in hemodialysis patients with osteomalacia, Kidney Int. 24: 364 369.

    PubMed  CAS  Google Scholar 

  103. Morrisey, J., Rothstein, M., Mayor, G., and Slatopolsky, E., 1983, Suppression of parathyroid hormone secretion by aluminum, Kidney Int. 23: 699 704.

    Google Scholar 

  104. Bordeau, A. M., Plachot, J. J., Cournot, G., Pointillart, A., Sachs, C., and Balsan, S., 1984, In vitro effects of aluminum on parathyroid cells: Correspondence between hormonal secretion and ultrastructural aspects, in: Endocrine Control of Bone and Calcium Metabolism, Volume 8A (D. V. Cohn, T. Fujita, J. T. Potts, Jr., and R. V. Talmage, eds.), Elsevier, Amsterdam, pp. 230 231.

    Google Scholar 

  105. Chertow, B. S., Baylink, D. J., Wergedal, J. E., Su, M. H. H., and Norman, A. W., 1975, Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vivo by 1,25-dihydroxy cholicalciferol, J. Clin Invest. 56: 668 678.

    PubMed  CAS  Google Scholar 

  106. Au, W. Y W. and Bukowsky, A., 1976, Inhibition of PTH secretion by vitamin D metabolites in organ cultures of rat parathyroids, Fed. Proc. 35: 530.

    Google Scholar 

  107. Dietel, M., Dorn, G., Montz, R., and Altenahr, G., 1979, Influence of vitamin D3, 1,25-dihydroxy vitamin D3 and 25,26-dihydroxy vitamin D3 on parathyroid hormone secretion, adenosine 3’,5’ monophosphate release and ultrastructure of parathyroid glands in organ culture, Endocrinology 105: 237 245.

    PubMed  CAS  Google Scholar 

  108. Canterbury, J. M. Lerman, S., Claflin, A. J., Henry, H., Norman, A., and Reiss, E., 1978, Inhibition of parathyroid hormone secretion by 25-dihydroxy cholecalciferol and 24,25-dihydroxy cholecalciferol in the dog, J. Clin. Invest. 61: 1375 1383.

    Google Scholar 

  109. Llach, F., Coburn, J. W., Brickman, A. S., Kurokawa, K., Norman, A. W., Canterbury, J. M., and Reiss, E., 1977, Acute actions of 1,25-dihydroxy vitamin D3 in normal man: Effect on calcium and parathyroid status, J. Clin. Endocr. Metab. 44: 1054 1060.

    PubMed  CAS  Google Scholar 

  110. Tanaka, Y., DeLuca, H. F., Ghazarian, J. G., Hargis, G. K., and Williams, J. A., 1979, Effect of vitamin D and its metabolites on serum parathyroid hormone levels in the rat, Miner. Electrolyte Metab. 2: 20 25.

    CAS  Google Scholar 

  111. Golden, P., Greenwalt, A., Martin, K., Bellorin-Font, E., Mazey, R., Klahr, S., and Slatopolsky, E., 1980, Lack of a direct effect of 1,25-dihydroxycholecalciferol on secretion of parathyroid hormone, Endocrinology 107: 602 607.

    PubMed  CAS  Google Scholar 

  112. Brumbaugh, P. F., Hughes, M. R., and Haussler, M. R., 1975, Cytoplasmic and nuclear binding components for 1,25-dihydroxy vitamin D3 in chick parathyroid glands, Proc. Natl. Acad. Sci. USA 72: 4871 4875.

    PubMed  CAS  Google Scholar 

  113. Silver, J., Russell, J., and Sherwood, L. M., 1985, Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells, Proc. Natl. Acad. Sci. USA 82: 4270 4273.

    PubMed  CAS  Google Scholar 

  114. Silver, J., Naveh, T., Mayer, H., Schmelzer, H., and Popovtzer, M., 1985, Regulation by 1,25-dihydroxy vitamin D3 of pre-pro-parathyroid hormone mRNA in vivo in: Abstracts of the 18th Annual Meeting of the American Society of Nephrology, 23 A, New Orleans.

    Google Scholar 

  115. Glover, D., Riley, L., Carmichael, K., Spar, B., Glick, J., Agus, Z., Slatopolsky, E., Attie, M., and Goldfarb, S. 1983, Hypocalcemia and inhibition of parathyroid hormone secretion following administration of WR 2721 (a radioand chemoprotective agent), N. Engl J. Med. 309: 1137 1141.

    PubMed  CAS  Google Scholar 

  116. Attie, M. F., Fallon, M. D., Spar, B., Wolf, J. S., Slatopolsky, E., and Goldfarb, S., 1985, Bone and parathyroid inhibitory effects of S-2(3-aminopropylamino) ethyl-phosphorothioc acid. Studies in experimental animals and cultured bone cells, J. Clin Invest. 75: 1191 1197.

    PubMed  CAS  Google Scholar 

  117. Hirschel-Scholz, S., Caversazio, J., and Bonjour, J-P., 1985, Inhibition of parathyroid hormone secretion and parathyroid hormone independent diminution of tubular calcium reabsorption by WR 2721, a unique hypocalcemic agent, J. Clin. Invest. 76: 1851 1856.

    PubMed  CAS  Google Scholar 

  118. Glover, D. J., Shaw, L., Glick, J. H., Slatopolsky, E., Weiler, C., Attie, M., and Goldfarb, S., 1985, Treatment of hypercalcemia in parathyroid cancer with WR 2721, S-2-(3-aminopropylamino)ethylphosphorothioic acid, Ann. Intern. Med. 103: 55 57.

    PubMed  CAS  Google Scholar 

  119. Rosenblatt, M., Horiuchi, N., Doppelt, S., Tyler, G. A., Goldring, S. R., Holick, M. F, Krane, S. M., Neer, M., and Potts, J. T. Jr., 1984, Parathyroid hormone-receptor interactions: Characterization of receptors and development of inhibitors effective in vivo, in: Endocrine Control of Bone and Calcium, Volume 8A ( D. V. Cohn, T. Fujita, J. T. Potts, Jr., and R. V. Talmage, eds.), Elsevier, Amsterdam, pp. 209 216.

    Google Scholar 

  120. Nussbaum, S. R., Rosenblatt, M., and Potts, J. T. Jr., 1980, Parathyroid hormone-renal receptor interactions. Demonstration of two receptor-binding domains, J. Biol Chem. 255: 10183 10187.

    PubMed  CAS  Google Scholar 

  121. Segre, G. V., Tully, G. L. Ill, Rosenblatt, M., Laugharn, J. A., Reit, B., and Potts, J. T. Jr., 1979, Calcif. Tissue Int. 18:171 (Abstr.).

    Google Scholar 

  122. Horiuchi, N., Rosenblatt, M., Keutmann, H. T., Potts, J. T. Jr., and Holick, M. F., 1983, A multiresponse parathyroid hormone assay: An inhibitor has agonist properties in vivo, Am. J. Physiol 80: E589 E595.

    Google Scholar 

  123. Martin, J. K., Bellorin-Font, E., Freitag, J., Rosenblatt, M., and Slatopolsky, E., 1981, The arterio-venous difference for immunoreactive parathyroid hormone and the production of adenosine 3’5’ monophosphate by isolated perfused bone: Studies with analogs of parathyroid hormone, Endocrinology 109: 956 959.

    PubMed  CAS  Google Scholar 

  124. Tyler, G. A. and Rosenblatt, M., 1983, Semi-preparative high performance liquid chromatographic purification of a 28-amino acid synthetic parathyroid hormone antagonist, J. Chromatogr. 266: 313 318.

    PubMed  CAS  Google Scholar 

  125. Strewler, G. J., Williams, R. D., and Nissenson, R. A., 1983, Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors, J. Clin. Invest. 71: 769 774.

    PubMed  CAS  Google Scholar 

  126. Coltrera, M. D., Potts, J. T. Jr., and Rosenblatt, M., 1981, Identification of a renal receptor for parathyroid hormone by photoaffinity radiolabelling using a synthetic analogue, J. Biol Chem. 256: 10555 10559.

    PubMed  CAS  Google Scholar 

  127. Draper, M. W., Nissenson, R. A., Winer, J., Ramachandran, J., and Arnaud, C. D., 1982, Photoaffinity labelling of the canine renal receptor for parathyroid hormone, J. Biol Chem. 257: 3714 3718.

    PubMed  CAS  Google Scholar 

  128. Berson, S. A., Yalow, R. S., Aurbach, G. D., and Potts, J. T. Jr., 1963, Immuno assay of bovine and human parathyroid hormone, Proc. Natl Acad. Sci. USA 49: 613 618.

    PubMed  CAS  Google Scholar 

  129. Mallette, L. E., 1984, Radioimmunoassays specific for the mid-region (4468) of parathyroid hormone, in: Endocrine Control of Bone and Calcium Metabolism, Volume 8B (D. V. Cohn, T. Fujita, J. T. Potts, Jr., and R. V. Talmage, eds.), Elsevier, Amsterdam, pp. 21 23.

    Google Scholar 

  130. Segre, G. V., 1984, Amino-terminal radioimmuno assays for human parathyroid hormone, in: Endocrine Control of Bone and Calcium Metabolism, Volume 8B (D. V. Cohn, T. Fujita, J. T. Potts, Jr., and R. V. Talmage, eds.), Elsevier, Amsterdam, pp. 17 30.

    Google Scholar 

  131. Goltzman, D., Henderson, B., and Loveridge, N., 1980, Cytochemical bioassay of parathyroid hormone: Characteristics of the assay and analysis of circulating hormonal forms, J. Clin. Invest. 65: 1309 1317.

    PubMed  CAS  Google Scholar 

  132. Lindall, A. W., Elting, J., Ellis, J., and Roos, B. A., 1983, Estimation of biologically active intact parathyroid hormone in normal and hyperparathyroid sera by sequential N-terminal immuno-extraction and midregion radio immunoassay,/. Clin. Endocr. Metab. 57: 1007 1014.

    CAS  Google Scholar 

  133. Wiejeyesinghe, E. C. R., Parnham, A. J., Farndon, J. R., and Wilkinson, R., 1984, Evaluation of the intact hormone assay in the study of parathyroid autograft function, Proc. Eur. Dial Transp. Assoc.-Eur. Ren. Assoc. 21: 426 430.

    Google Scholar 

  134. Massry, S. G., 1983, The toxic effects of parathyroid hormone in uremia, Semin. Nephrol 3: 306 328.

    CAS  Google Scholar 

  135. Akmal, M., Telfer, N., Ansari, A. N., and Massry, S. G., 1985, Erythrocyte survival in chronic renal failure. Role of secondary hyperparathyroidism, J. Clin. Invest. 76: 1695 1698.

    PubMed  CAS  Google Scholar 

  136. McGonigle, R. J. S., Wallen, J. D., Husserl, F., Deftos, L. J., Rice, J. C., O’Neill, W. J., Jr., and Fisher, J. W., 1984, Potential role of PTH as an inhibitor of erythropoiesis in the anemia of renal failure, J. Lab. Clin. Med. 104: 1016 1026.

    PubMed  CAS  Google Scholar 

  137. Amara, S. G., Jonas, V., Rosenfeld, M. G., Ong, E. S., and Evans, R. M., 1982, Alternative RNA processing in calcitonin gene expression generates nRNAs encoding different polypeptide products, Nature 298: 240 244.

    PubMed  CAS  Google Scholar 

  138. Rosenfeld, M. G., Mermod, J-J., Amara, S. G., Swanson, L. W., Sawchenko, P. E., Rivier, J., Vale, W. W., and Evans, R. M., 1983, Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing, Nature 304: 129 135.

    PubMed  CAS  Google Scholar 

  139. Roos, B. A., O’Neill, J. A., Muszynski, M., and Birnbaum, R. S., 1984, Noncalcitonin secretory products of calcitonin gene expression, in: Endocrine Control of Bone and Calcium Metabolism, Volume 8A (D. V. Cohn, T. Fujita, J. T. Potts, Jr., and R. V. Talmage, eds.), Elsevier, Amsterdam, pp. 169 175.

    Google Scholar 

  140. Struthers, A. D., Brown, M. J., MacDonald, D. W. R., Beacham, J. L., Stevenson, J. C., Morris, H. R., and Maclntyre, R., 1986, Human calcitonin gene related peptide: A potent endogenous vasodilator in man, Clin. Sci. 70: 389 393.

    PubMed  CAS  Google Scholar 

  141. Hillyard, C. J., Myers, C., Abeyasekera, G., Stevenson, J. C., Craig, R. K., and Maclntyre, I., 1983, Katakalcin: A new plasma calcium-lowering hormone, Lancet 1: 846 848.

    PubMed  CAS  Google Scholar 

  142. Sutton, R. A. L. and Dirks, J. H., 1986, Calcium and magnesium: Renal handling and disorders of metabolism, in: The Kidney ( B. M. Brenner and F. C. Rector, Jr., eds.), Saunders, Philadelphia, pp. 551 618.

    Google Scholar 

  143. Bomsztyk, K., George, J. P., and Wright, F. S., 1984, Effects of luminal fluid anions on calcium transport by proximal tubule, Am. J. Physiol. 246: F600 F608.

    PubMed  CAS  Google Scholar 

  144. Ullrich, K. J., Rumrich, G., and Kloss, S., 1976, Active Ca++ reabsorption in the proximal tubule of the rat kidney, Pflüegers Arch. 364: 223 228.

    CAS  Google Scholar 

  145. Ng, R. C. K., Rouse, D., and Suki, W. N., 1984, Calcium transport in the rabbit superficial proximal convoluted tubule, J. Clin. Invest. 74: 834 842.

    PubMed  CAS  Google Scholar 

  146. Bourdeau, J. E., 1985, Calcium transport across cortical segment two proximal tubules, in: Abstracts of the 18th Annual Meeting of the American Society of Nephrology, 6 A, New Orleans.

    Google Scholar 

  147. Scoble, J. E., Mills, S., and Hruska, K. A., 1985, Calcium transport in canine renal basolateral membrane vesicles. Effects of parathyroid hormone, J. Clin. Invest. 75: 1096 1105.

    PubMed  CAS  Google Scholar 

  148. Taylor, A. and Windhager, E. E., 1979, Possible role of cytosolic calcium and Na-Ca exchange in regulation of transepithelial sodium transport, Am. J. Physiol. 236: F505 F512.

    PubMed  CAS  Google Scholar 

  149. Bourdeau, J. E. and Burg, M. B., 1979, Voltage dependence of calcium transport in the thick ascending limb of Henle’s loop, Am. J. Physiol. 236: F357 F364.

    PubMed  CAS  Google Scholar 

  150. Suki, W. N., Rouse, D., Ng, R. C. K., and Kokko, J. P., 1980, Calcium transport in the thick ascending limb of Henle: Heterogeneity of function in the medullary and cortical segments, J. Clin. Invest. 66: 1004 1009.

    CAS  Google Scholar 

  151. Greger, R., Schlatter, E., and Lang, F., 1983, Evidence for electroneutral sodium chloride cotransport in the cortical thick ascending limb of Henle’s loop of rabbit kidney, Pfleügers Arch. 396: 308 314.

    CAS  Google Scholar 

  152. Shareghi, G. T. and Agus, Z. S., 1982, Magnesium transport in the cortical thick ascending limb of Henle’s loop of the rabbit, J. Clin. Invest. 69: 759 769.

    PubMed  CAS  Google Scholar 

  153. Ziyadeh, F. N., Kelepouris, E., Civan, M. M., and Agus, Z. S., 1985, cAMP and B-adrenergic-stimulated chloride-dependent Ca2+ secretion in frog skin, Am. J. Physiol 249: F713 F722.

    Google Scholar 

  154. Frizzel, R. A., Welsh, M. J., and Smith, P. L., 1981, Electrophysiology of chloride-secreting epithelia, in: Ion Transport by Epithelia ( S. G. Schultz, ed), Raven Press, New York, pp. 137 149.

    Google Scholar 

  155. Agus, Z. S., Mechanisms of calcium transport in the thick ascending loop of Henle, presented at 7th International Workshop on Phosphate and Other Minerals, Marseille, France, Sept. 1985.

    Google Scholar 

  156. Bourdeau, J. E. and Hellstrom-Stein, R. J., 1982, Voltage dependent calcium movement across the cortical collecting duct, Am. J. Physiol. 242: F285 F292.

    PubMed  CAS  Google Scholar 

  157. Puschett, J. B., Morantz, J., and Kurnick, W. S., 1972, Evidence for a direct action of cholecalciferol and 25-hydroxy cholecalciferol on the renal transport of phosphate, sodium and calcium, J. Clin. Invest. 51: 373 385.

    PubMed  CAS  Google Scholar 

  158. Costanzo, L. S., Sheehe, P. R., and Weiner, I. M., 1974, Renal action of vitamin D in D-deficient rats, Am. J. Physiol. 226: 1490 1495.

    PubMed  CAS  Google Scholar 

  159. Bonjour, J. P., Trechsel, U., Fleisch, H., Schenk, R., DeLuca, H. F., and Baxter, L. A., 1975, Action of 1,25-dihydroxy D3 and a diphosphonate on calcium metabolism in rats, Am. J. Physiol 229:489–495.

    Google Scholar 

  160. Rizzoli, R., Fleisch, H., and Bonjour, J. P., 1977, Effect of thyroparathyroidectomy on calcium metabolism in rats: Role of l,25(OH)2D3, Am. J. Physiol 233: E160 E164.

    PubMed  CAS  Google Scholar 

  161. Burnatowska, M. A., Harris, C. A., Sutton, R. A. L., and Seely, J. F., 1985, The effects of vitamin D on renal handling of calcium, magnesium, and phosphate in the hamster, Kidney Int. 27: 864 870.

    PubMed  CAS  Google Scholar 

  162. Costanzo, L. S., 1984, Comparison of calcium and sodium transport in early and late rat distal tubules: Effect of amiloride, Am. J. Physiol 246.-F937-F945.

    Google Scholar 

  163. Maschio, G., Tessitore, N., D’Angelo, D. A., Fabris, A., Pogano, F., Tasca, A., Graziani, G., Aroldi, A., Surian, M., Colussi, G., Mandressi, A., Trinchieri, A., Rocco, F., Ponticelli, C., and Minetti, L., 1981, Prevention of calcium lithiasis with low dose thiazide, amiloride and allopurinol, Am. J. Med. 71: 623 626.

    PubMed  CAS  Google Scholar 

  164. Alon, V., Costanzo, L., and Chan, J. C. M., 1984, Additive hypocalciuric effects of amiloride and hydrochlorothiazide in patients treated with calcitriol, Miner. Electrolyte Metab. 10: 379 386.

    PubMed  CAS  Google Scholar 

  165. Guruprakash, G. H., Babino, H., Duffy, W. B., Krothapalli, R. K., Senekjian, H. O., Eknoyan, G., and Sukie, W. N., 1985, Microinjection study of renal calcium absorption in the phosphate-depleted rat, Miner. Electrolyte Metab. 11: 262 266.

    PubMed  CAS  Google Scholar 

  166. Costanzo, L. S., and Adler, R. A., 1985, Chronic prolactin excess causes hypercalciuria: A direct renal effect, in: Abstracts of the 18th Annual Meeting of the American Society of Nephrology, 9A, New Orleans.

    Google Scholar 

  167. Murray, T. M., Peacock, M., Powell, D., Monchik, J. M., and Potts, J. T. Jr., 1972, Non-autonomy of hormone secretion in primary hyperparathyroidism, Clin. Endocrinol (Oxford) 1: 235 246.

    CAS  Google Scholar 

  168. Bouillon, R., and deMoor, P., 1973, Pathophysiological data obtained with a radioimmunoassay for human parathyroid hormone, Ann. Endocr. (Paris) 34: 657 668.

    CAS  Google Scholar 

  169. Reiss, E. and Canterbury, J. M., 1969, Primary hyperparathyroidism: Application of radioimmunoassay to differentiation of adenoma and hyperplasia and the preoperative localization of hyperfunctioning parathyroid glands, N. Engl. J. Med. 280: 1381 1385.

    PubMed  CAS  Google Scholar 

  170. Broadus, A. E., Deftos, L. J., and Bartter, F. C., 1978, Effects of the intravenous administration of calcium on nephrogenous cyclic AMP; use as a parathyroid suppression test, J. Clin. Endocr. Metab. 46: 477 487.

    PubMed  CAS  Google Scholar 

  171. Brown, E. M., Broadus, A. E., Brennan, M. F., Gardner, D. G., Marx, S. J., Spiegel, A. M., Downs, R. W. Jr., Attie, M., and Aurbach, G. D., 1979, Direct comparison in vivo and in vitro of suppressibility of parathyroid function by calcium in primary hyperparathyroidism, J. Clin. Endocr. Metab. 48: 604 610.

    PubMed  CAS  Google Scholar 

  172. Insogna, K. L., Mitnick, M. E., Stewart, A. F., Burtis, W. J., Mallette, L. E., and Broadus, A. E., 1985, Sensitivity of the parathyroid hormone-1,25-Dihydroxy vitamin D axis to variations in calcium intake in patients with primary hyperparathyroidism, N. Engl. J. Med. 313: 1126 1130.

    PubMed  CAS  Google Scholar 

  173. Gardin, J. P. and Paillard, M., 1984, Normocalcemic primary hyperparathyroidism: Resistance to PTH effect to tubular reabsorption of calcium, Miner. Electrolyte Metab. 10: 301 308.

    PubMed  CAS  Google Scholar 

  174. Bordier, P., Ryckewaert, A., Gueris, J., and Rasmussen, H., 1977, On the pathogenesis of so called idiopathic hypercalciuria, Am. J. Med. 63: 398 409.

    PubMed  CAS  Google Scholar 

  175. Edis, A. J. and Evans, T. C., 1979, High resolution real time ultrasonography in the preoperative localization of parathyroid tumours, N. Engl. J. Med. 301: 532 534.

    PubMed  CAS  Google Scholar 

  176. Brewer, W. H., Walsh, J. W., and Newsome, H. H., 1983, Impact of sonography on surgery for primary hyperparathyroidism, Am. J. Surg. 145: 270 272.

    PubMed  CAS  Google Scholar 

  177. Clark, O. H., Stark, D. A., Duh, Q-Y., Arnaud, C.D., and Gooding, G. A. W., 1985, Value of high resolution, real-time ultrasonography in secondary hyperparathyroidism, Am. J. Surg. 150: 9 17.

    PubMed  CAS  Google Scholar 

  178. Young, A. E., Gaunt, J. I., Croft, D. N., Collins, R. E. C., Wells, C. P., and Coakley, A. J., 1983, Localization of parathyroid adenomas by thallium 201 and technetium 99M subtraction scanning, Br. Med. J. 286: 1384 1386.

    CAS  Google Scholar 

  179. Wheeler, M. H., Harrison, B. J., French, A P., and Leach, K. G., 1984, Preliminary results of thallium 201 and technetium 99M subtraction scanning of parathyroid glands, Surgery 96: 1078 1082.

    PubMed  CAS  Google Scholar 

  180. Okerlund, M. D., Sheldon, K., Corpuz, S., O’Connell, W., Faulkner, D., Clark, O., and Galante, M., 1984, A new method with high sensitivity and specificity for localization of abnormal parathyroid glands, Ann. Surg. 200: 381 388.

    PubMed  CAS  Google Scholar 

  181. Clark, O. H., Stark, D., Gooding, G., Moss, A., Arnaud, S., Newton, T. H., Norman, D., Bank, W. O., and Arnaud, C. D., 1984, Localization procedures in patients requiring reoperation for hyperparathyroidism, World J. Surg. 8: 509 521.

    PubMed  CAS  Google Scholar 

  182. Esselstyn, C. B. and Buonocore, E., 1983, The use of digital subtraction angiography and computed tomography scanning in localization of parathyroid adenomas in secondary parathyroid operations: Preliminary observations, Surgery 94: 869 872.

    PubMed  Google Scholar 

  183. Krudy, A. G., Koppmann, J. L., Miller, D. L., Norton, J. A., Marx, S. J., Spiegel, A. M., Santara, A. C., Aurbach, G. D., and Schaaf, M., 1984, Detection of mediastinal parathyroid glands by nonselective digital arteriography, Am. J. Radiol. 142: 693 695.

    CAS  Google Scholar 

  184. Eisenberg, H., Pallotta, J., and Sherwood, L. M., 1974, Selective arteriography, venography and venous hormone assay in diagnosis and localization of parathyroid lesions, Am. J. Med. 56: 810 820.

    PubMed  CAS  Google Scholar 

  185. Brennan, M. F., Doppmann, J. L., Kurdy, A. G., Marx, S. J., Spiegel, A. M., and Aurbach, G. D., 1982, Assessment of techniques for preoperative parathyroid localization in patients undergoing reoperation for hyperparathyroidism, Surgery 91: 6 11.

    PubMed  CAS  Google Scholar 

  186. Hsu, F. S. F., Clark, O. H., Serata, T. Y., and Nissenson, R. A., 1983, Rapid localization of parathyroid tumors by selective venous catheterization and parathyroid hormone bioassay, Surgery 94: 1873 876.

    Google Scholar 

  187. Clark, O. H., Gooding, G. A., and Ljung, B. M., 1981, Locating a parathyroid adenoma by ultrasonography and aspiration biopsy cytology, West. J. Med. 135: 154 158.

    PubMed  CAS  Google Scholar 

  188. Doppmann, J. L., Krudy, A. G., Marx, S. J., et al., 1983, Aspiration of enlarged parathyroid glands for parathyroid hormone assay, Radiology 148:31–35

    Google Scholar 

  189. Krudy, A. G., Doppmann, J. L., Marx, S. J., Norton, J. A., Spiegel, A. M., Santara, A. C., and Aurbach, G. D., 1984, Parathyroid aspiration directed by angiography—An alternative to venous sampling, Radiology 152: 207 208.

    PubMed  CAS  Google Scholar 

  190. Heath, H. Ill, Hodgson, S. F., Kennedy, M. A., 1980, Primary hyperparathyroidism: Incidence, morbidity and potential economic impact in a community, N. Engl. J. Med. 301: 189 193.

    Google Scholar 

  191. Paterson, C. R., Burns, J. and Mowat, E., 1985, Long term follow-up of untreated primary hyperparathyroidism, Br. Med. J. 2: 1261 1263.

    Google Scholar 

  192. Bilezikian, J. P., 1985, Surgery or no surgery for primary hyperparathyroidism, Ann. Intern. Med. 102: 402 403.

    PubMed  CAS  Google Scholar 

  193. Talpos, G. B., Kleerekoper, M., Kambouris, A., and Moore, D. R., 1983, Management of primary hyperparathyroidism, in: Clinical Disorders of Bone and Mineral Metabolism ( B. Frame, and J. T. Potts, Jr., eds.), Excerpta Medica, Amsterdam, pp. 537 539.

    Google Scholar 

  194. Douglas, D. L., Kanis, J. A., Paterson, A. D., Beard, D. J., Cameron, E. C., Watson, M. E., Woodhead, S., Williams, J., and Russell, R. G. G., 1983, Drug treatment of primary hyperparathyroidism: Use of clodronate disodium, Br. Med. J. 286: 587 590.

    CAS  Google Scholar 

  195. Marcus, R., Modvig, P., Crim, M., Pont, A., and Kosek, J., 1984, Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism, Ann. Intern. Med. 100: 633 640.

    PubMed  CAS  Google Scholar 

  196. Rasbach, D. A., Monchik, J. M., Geelhoed, G. W., and Harrison, T. S., 1984, Solitary parathyroid microadenoma, Surgery 96: 1092 1098.

    PubMed  CAS  Google Scholar 

  197. Saxe, A. W., Baier, R., Tesluk, H., and Toreson, W., 1985, The role of the pathologist in the surgical treatment of primary hyperparathyroidism, Surg. Gynecol. Obst. 161: 101 105.

    CAS  Google Scholar 

  198. Wells, S. A., Farndon, J. R., Dale, J. K., Leight, G. S., and Dilley, W. G., 1980, Long term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation, Ann. Surg. 192: 451 458.

    PubMed  Google Scholar 

  199. Spiegel, A. M., Downs, R. W., Santara, A., Marx, S. J., Doppmann, J., and Skull, J., 1983, Persistent hyperparathyroidism caused by incomplete parathyroid resection and a hyperfunctioning parathyroid autograft, JAMA 250: 1896 1898.

    PubMed  CAS  Google Scholar 

  200. Bondeson, A-G., Bondeson, L., Ljungberg, O., and Tibblin, S., 1985, Surgical strategy in non-familiar primary parathyroid hyperplasia: Long term follow-up of thirty-nine cases, Surgery 97: 569 573.

    PubMed  CAS  Google Scholar 

  201. Rattner, D. W., Marrone, G. C., Kasdon, E., and Silen, W., 1985, Recurrent hyperparathyroidism due to implantation of parathyroid tissue, Am. J. Surg. 149: 745 748.

    PubMed  CAS  Google Scholar 

  202. Goolhoed, G. W., Krudy, A. G., and Doppmann, J. L., 1983, Long term follow-up of patients with hyperparathyroidism treated by transcatheter staining with contrast agent, Surgery 94: 849 862.

    Google Scholar 

  203. Foley, T P., Harrison, H. C., Arnaud, C. D., and Harrison, H. E., 1972, Familial benign hypercalcemia, J. Pediatr. 81: 1060 1067.

    PubMed  Google Scholar 

  204. Law, W. M. and Heath, H. Ill, 1985, Familial benign hypercalcemia (hypocalciuric hypercalcemia.) Clinical and pathogenetic studies in 21 families, Ann. Intern. Med. 102: 511 519.

    PubMed  Google Scholar 

  205. Davies, M., Adams, P. H., Berry, J. L., Lumb, G. A., Klimiuk, P. S., Mawer, E. B., and Wain, D., 1983, Familial hypocalciuric hypercalcemia: Observations on vitamin D metabolism and parathyroid function, Acta Endocr. 104: 210 215.

    PubMed  CAS  Google Scholar 

  206. Allgrove, J., Sangal, A. K., Low, D. C., Weller, P. H., and Loveridge, N., 1984, Biologically active parathyroid hormone in familiar hypocalciuric hypercalcemia, Clin. Endocr. (Oxford) 21: 293 298.

    CAS  Google Scholar 

  207. Law, W. M., Carney, J. A., and Heath, H. Ill, 1984, Parathyroid glands in familial benign hypercalcemia (familiar hypocalciuric hypercalcemia), Am. J. Med. 76: 1021 1026.

    PubMed  Google Scholar 

  208. Attie, M. F., Gill, J. R. Jr., Stock, J. L. Spiegel, A. M., Downs, R. W., Jr., Levine, M. A., and Marx, S. J., 1983, Urinary calcium excretion in familiar hypocalciuric hypercalcemia, J. Clin. Invest. 72: 667 676.

    Google Scholar 

  209. Watanabe, H. and Sutton, R. A. L., 1983, Renal calcium handling in familial hypocalciuric hypercalcemia, Kidney Int. 24: 353 357.

    PubMed  CAS  Google Scholar 

  210. Sutton, R. A. L., Wong, N. L. M., Quamme, G. A., and Dirks, J. H., 1983, Renal tubular calcium transport; effects of changes in filtered calcium load, Am. J. Physiol. 245: F515 F520.

    PubMed  CAS  Google Scholar 

  211. Hoare, S. F. and Paterson, C. R., 1984, Familial benign hypercalcemia: A possible abnormality in calcium transport by erythrocytes, Eur. J. Clin. Invest. 14: 428 430.

    PubMed  CAS  Google Scholar 

  212. Mole, P. A. and Paterson, C. R., 1985, Calcium-ATPase activity in erythrocyte ghosts from patients with familial benign hypercalcemia, Scand. J. Lab. Invest. 45: 349 353.

    CAS  Google Scholar 

  213. Marx, S. J., Attie, M. F., Spiegel, A. M., Levine, M. A., Lasker, R. D., and Fox, M., 1982, An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia, N. Engl. J. Med. 306: 257 264.

    PubMed  CAS  Google Scholar 

  214. Marx, J. S., Fraser, D., and Rapoport, A., 1984, Familial hypocalciuric hypercalcemia. Mild expression of the gene in heterozygotes and severe expression in homozygotes, Am. J. Med. 78: 15 22.

    Google Scholar 

  215. Kirschbaum, B. B., Sica, D. A., Horn, B. M., and Newsome, H. H., 1983, Hypocalciuric hyperparathyroidism with chronic renal failure, South. Med. J. 76: 1075 1076.

    PubMed  CAS  Google Scholar 

  216. Zaloga, G. P., Eil, C., and O’Brian, J. T., 1984, Reversible hypocalciuric hypercalcemia associated with hyperthyroidism, Am. J. Med. 77: 1101 1104.

    PubMed  CAS  Google Scholar 

  217. Mundy, G. R., Ibbotson, K. J., D’Souza, S. M., Simpson, E. L., Jacobs, J W., and Martin, T. J., 1984, The hypercalcemia of cancer: Clinical implications and pathogenic mechanisms, N. Engl. J. Med. 310: 1718 1727.

    PubMed  CAS  Google Scholar 

  218. Mundy, G. R., Ibbotson, K. J., and D’Souza, S. M., 1985, Tumor products and the hypercalcemia of malignancy, J. Clin. Invest. 76: 391 394.

    PubMed  CAS  Google Scholar 

  219. Bunn, P. A. Jr., Schechter, G. P., Jaffe, E., Blayney, D., Young, R. C., Matthews, M. J., Blattner, W., Broder, S., Robert-Guroff, M., and Gallo, R. C., 1983, Clinical course of retrovirus associated adult T-cell lymphoma in the United States, N. Engl. J. Med. 309: 257 264.

    PubMed  Google Scholar 

  220. Jilka, R. L. and Hamilton, J. W., 1984, Inhibition of parathormone-stimulated bone resorption by large I interferon, Biochem. Biophys. Res. Commun. 120: 553 558.

    PubMed  CAS  Google Scholar 

  221. Gowen, M., Wood, D. D., Ihrie, E. J., McGuire, M. K. B., and Russell, R. G. G., 1983, An interleukin-1 like factor stimulates bone resorption in vitro, Nature 306: 378 380.

    CAS  Google Scholar 

  222. Mason, R. S., Frankel, T., Chan, Y. L., Lissner, D., and Posen, S., 1984, Vitamin D conversion by sarcoid lymph node homogenate, Ann. Intern. Med. 100: 59 61.

    PubMed  CAS  Google Scholar 

  223. Breslau, N. A., McGuire, J. L., Zerwekh, J. E., Frenkel, E. P., and Pak, C. Y. C., 1984, Hypercalcemia associated with increased serum calcitriol levels in 3 patients with lymphoma, Ann. Intern. Med. 100: 1 7.

    PubMed  CAS  Google Scholar 

  224. Valentin-Opran, A., Eilon, G., Saez, S., and Mundy, G. R., 1985, Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells, J. Clin. Invest. 75: 726 731.

    PubMed  CAS  Google Scholar 

  225. Simpson, E. L., Mundy, G. R., D’Souza, S. M., Ibbotson, K. J., Bockman, R., and Jacobs, J. W., 1983, Absence of parathyroid hormone messenger RNA in nonparathyroid tumors associated with hypercalcemia, N. Engl. J. Med. 309: 325 330.

    PubMed  CAS  Google Scholar 

  226. Rodan, S. B., Insogna, K. L., Vignery, A. M.-C., Stewart, A. F., Broadus, A. E., D’Souza, S. M., Bertollini, D. R., Mundy, G. R., and Rodan, G. A., 1983, Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells, J. Clin. Invest. 72: 1511 1515.

    PubMed  CAS  Google Scholar 

  227. Strewler, G. J., Williams, R. D., and Nissenson, R. A., 1983, Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors, J. Clin. Invest. 71: 769 774.

    PubMed  CAS  Google Scholar 

  228. Roberts, A. B., Frolik, C. A., Anzano, M. A., and Sporn, M. B., 1983, Transforming growth factors from neoplastic and non-neoplastic tissues, Fed. Proc. 42: 2621 2625.

    PubMed  CAS  Google Scholar 

  229. Ibbotson, K. J., D’Souza, S. M., Ng, K. W., Osborne, C. K., Niall, M., Martin, T. J., and Mundy, G. R., 1983, Tumor derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy, Science 221: 1292 1294.

    PubMed  CAS  Google Scholar 

  230. Deuel, T. F., Huang, J. S., Huang, S. S., Stroobant, P., and Waterfield, M. D. 1983, Expression of a platelet derived growth factor-like protein in simian sarcoma virus transformed cells, Science 221: 1348 1350.

    PubMed  CAS  Google Scholar 

  231. Doolittle, R. F., Hunkapiller, W. M., Hood, L. E., Devare, S. G., Robbins, K. C., Aaronson, S. A., and Antoniades, H. W., 1983, Simian sarcoma virus oncogene v-sis, is derived from the gene (or genes) encoding a plateletderived growth factor, Science 221: 275 277.

    PubMed  CAS  Google Scholar 

  232. Stern, P. H., Krieger, N. S., Nissenson, R. A., Williams, R. D., Winkler, M. E. Derynck, R., and Strewler, G. J., 1985, Human transforming growth factor alpha stimulates bone resorption in vitro,/. Clin. Invest. 76: 2016 2019.

    Google Scholar 

  233. Ralston, S. H., Fogelman, I., Gardner, M. D., Dryburgh, F. J., Cowan, R. A., and Boyle, I. T., 1984, Hypercalcemia of malignancy. Evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium, Clin. Sci. 66: 187 191.

    PubMed  CAS  Google Scholar 

  234. Caverzasio, J., Rizzoli, R., Fleisch, H., and Bonjour, J. P., 1984, PTH-like changes of renal calcium and phosphate [Pi] reabsorption induced by Leydig cell tumor in thyroparathyroidectomized [TPTX] rats, Calcified Tissues Int. 36: S26.

    Google Scholar 

  235. Boyd, J. C. and Ladenson, J. H., 1984, Value of laboratory tests in the differential diagnosis of hypercalcemia, Am. J. Med. 77: 863 872.

    PubMed  CAS  Google Scholar 

  236. Sharma, O. P., 1984, Sarcoidosis, Clinical Management, Butterworths, London, pp. 145 149.

    Google Scholar 

  237. Adams, J. S., Sharma, O. P., Gacad, M. A., and Singer, F. R., 1983, Metabolism of 25-hydroxy vitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis,/. Clin. Invest. 72: 1856 1860.

    CAS  Google Scholar 

  238. Kozeny, G. A., Barbato, A. L., Bansal, V. K., Vertuno, L. L., and Hano, J. E., 1984, Hypercalcemia associated with silicone-induced granulomas, N. Engl. J. Med. 311: 1103 1105.

    PubMed  CAS  Google Scholar 

  239. Cohen, M. S. and Gray, T. K., 1984, Phagocytic cells metabolize 25-hydroxy vitamin D3 in vitro, Proc. Natl. Acad. Sci. USA 81: 931 934.

    CAS  Google Scholar 

  240. Lemann, J., Jr. and Gray R. W., 1984, Calcitriol, calcium and granulomatous disease, N. Engl. J. Med. 311: 1115 1117.

    PubMed  Google Scholar 

  241. Davies, M., Mawer, E. B., Hayes, M. E., and Lumb, G. A., 1985, Abnormal vitamin D metabolism in Hodgkin’s lymphoma, Lancet 1: 1186 1188.

    PubMed  CAS  Google Scholar 

  242. Zaloga, G P., Chernow, B., and Eil, C., 1985, Hypercalcemia and disseminated cytomegalovirus infection in the acquired immunodeficiency syndrome, Ann. Intern. Med. 102: 331 333.

    PubMed  CAS  Google Scholar 

  243. Farfel, Z., Brothers, V. M., Brickman, A. S., Conte, F., Neer, R., and Bourne, H. R., 1981, Pseudohypoparathyroidism; Inheritance of deficient receptor cyclase coupling activity, Proc. Natl. Acad. Sci. USA 78: 3098 3102.

    PubMed  CAS  Google Scholar 

  244. Spiegel, A. M., Levine, M. A., Marx, S. J., and Aurbach, G. D., 1982, Pseudohypoparathyroidism: The molecular basis for hormone resistance— A retrospective, N. Engl. J. Med. 307: 679 681.

    PubMed  CAS  Google Scholar 

  245. Fischer, J. A., Bourne, H. R., Dambacher, M. A., Tschopp, F., DeMeyer, R., Devogelaer, J. P., Werder, E. A., and Nagant de Deuxchaisnes, C., 1983, Pseudohypoparathyroidism. Inheritance and expression of deficient receptor cyclase coupling protein activity, Clin. Endocr. (Oxford) 19: 747 754.

    CAS  Google Scholar 

  246. Hurley, J. B., Simon, M. I., and Teplow, D. B., 1984, Homologies between signal transducing G proteins and ras gene products, Science 226: 860 862.

    PubMed  CAS  Google Scholar 

  247. Fischer, J. A., Nagant de Deuxchaisnes, C., Loveridge, N., Dambacher, M. A., Tschopp, F. A., Werder, E., Bitensky, L., and Chayen, J., 1984, The diagnosis of pseudohypoparathyroidism type I, in: Endocrine Control of Bone and Calcium Metabolism, Volume 8B (D. V. Cohn, T. Fujita, J. T. Potts, Jr., and R. V. Talmage, eds.), Elsevier, Amsterdam, pp. 66 68.

    Google Scholar 

  248. Allgrove, J., Chayen, J., Jayaweera, P., and O’Riordan, J. L. H., 1984, An investigation of the biological activity of parathyroid hormone in pseudohypoparathyroidism compared with vitamin D deficiency, Clin. Endocr. (Oxford) 20: 503 514.

    CAS  Google Scholar 

  249. Bhattacharya, S. K., Luther, R.W., Pate, J. W., Crawford, A. J., Moore, O. F., Pitcock, J. A., Palmieri, G. M. A., and Britt, L. G., 1985, Soft tissue calcium and magnesium content in acute pancreatitis in the dog: Calcium accumulation, a mechanism for hypocalcemia in acute pancreatitis, J. Lab. Clin. Med. 105: 422 427.

    PubMed  CAS  Google Scholar 

  250. Levine, S. N. and Rheams, C. N., 1985, Hypocalcemic heart failure, Am. J. Med. 78: 1033 1035.

    PubMed  CAS  Google Scholar 

  251. Schmiedt, E. and Chaussy, C., 1984, Extracorporeal shock wave litrotripsy (ESWL) of kidney and ureteric stones, Int. Urol. Nephrol. 16: 273 284.

    PubMed  CAS  Google Scholar 

  252. Mulley, A. G., Jr., 1986, Shock-wave lithotripsy: Assessing a slam-bang technology, N. Engl. J. Med. 314: 845 847.

    PubMed  Google Scholar 

  253. Sutton, R. A. L., 1983, Disorders of renal calcium excretion, Kidney Int. 23: 665 673.

    PubMed  CAS  Google Scholar 

  254. Backman, U., Danielson, B. G., Johansson, G., Ljunghall, S., and Wickstrom, B., 1980, Incidence and clinical importance of renal tubular defects in recurrent renal stoneformers, Nephron 25: 96 101.

    PubMed  CAS  Google Scholar 

  255. Sutton, R. A. L. and Walker, V. R., 1980, Responses to hydrochlorothiazide and acetozolamide in patients with calcium stones, N. Engl. J. Med. 302: 709 713.

    PubMed  CAS  Google Scholar 

  256. Lau, Y. K., Wasserstein, A., Westby, G. R., Bosanac, P., Grabie, M., Mitnick, P., Slatopolsky, E., Goldfarb, B., and Agus, Z. S., 1982, Proximal tubular defects in idiopathic hypercalciuria—Resistance to phosphate administration, Miner. Electrolyte Metab. 7: 237 249.

    PubMed  CAS  Google Scholar 

  257. Sakhaee, K., Nicar, M. J., Brater, C., and Pack, C. Y. C., 1985, Exaggerated natriuretic and calciuric responses to hydrochlorothiazide in renal hyper calciuria but not in absorptive hypercalciuria, J. Clin. Endocr. Metab. 61: 825 829.

    PubMed  CAS  Google Scholar 

  258. Jaeger, P., Portmann, L., Ginalski, J-M., Jaquet, A.-F., Temler, E., and Burckhardt, P., 1986, Tubulopathy in nephrolithiasis—Consequence rather than cause, Kidney Int. 29: 563 571.

    PubMed  CAS  Google Scholar 

  259. Lau, Y. K. and Eby, K., 1982, Tubular mechanisms for the spontaneous hypercalciuria in laboratory rat, J. Clin. Invest. 70: 835 844.

    PubMed  CAS  Google Scholar 

  260. Lau, K., Thomas, D., Langman, C., and Eby, B., 1985, Pathophysiology of spontaneous hypercalciuria in laboratory rats. Role of deranged vitamin D metabolism, J. Clin. Invest. 76: 420 425.

    PubMed  CAS  Google Scholar 

  261. Coe, F. L., Favus, M. J., Crocket, T., Strauss, A. L. Parks, J. H., Porat, A., Gant, C. L., and Sherwood, L. M., 1982, Effects of low calcium diet on urine calcium excretion, parathyroid function and serum 1,25 (OH)2D3 levels in patients with idiopathic hyercalciuria and in normal subjects, Am. J. Med 72: 25 32.

    Google Scholar 

  262. Shen, F. H., Baylink, D. J., Nielson, R. L., Sherrard, D. J., Ivey, J. L., and Haussler, M. R., 1977, Increased 1,25-dihydroxy vitamin D in idiopathic hypercalciuria, J. Lab. Clin. Med. 19: 955 962.

    Google Scholar 

  263. Broadus, A. E., Insogna, A. L., Lang, R., Ellison, A. F., and Dreyer, B., 1984, Evidence for disordered control of 1,25-dihydroxy vitamin D production in absorptive hypercalciuria, N. Engl. J. Med. 311: 73 80.

    PubMed  CAS  Google Scholar 

  264. Netelenbos, J. C., Jongen, M. J. M., van der Vijgh, J. F., Lips, P., and van Ginkel, F. C., 1985, Vitamin D in urinary calcium stone formation, Arch. Interm. Med. 145: 681 684.

    CAS  Google Scholar 

  265. Sutton, R. A. L. and Walker, V. R., 1986, Bone resorption and hypercalciuria in calcium stoneformers, Metabolism 35: 485 488.

    PubMed  CAS  Google Scholar 

  266. Mautalen, C. A., 1970, Circadian rhythm of urinary total and free hydroxy proline excretion and its relation to creatinine excretion, J. Lab. Clin. Med. 75: 11 18.

    PubMed  CAS  Google Scholar 

  267. Agus, Z. S., 1983, Oncogenic hypophosphatemic osteomalacia, Kidney Int. 24: 113 123.

    PubMed  CAS  Google Scholar 

  268. Maierhofer, W. J., Gray, W., Chiung, H. S., and Lemann, J., Jr., 1983, Bone resorption stimulated by elevated serum 1,25 OH2 vitamin D concentrations in healthy men, Kidney Int. 24: 555 560.

    PubMed  CAS  Google Scholar 

  269. Maierhofer, W. J., Lemann, J. Jr., Gray, W., and Chiung, H. S., 1984, Dietary calcium and serum 1,25 OH2 vitamin D concentrations as determinants of calcium balance in healthy men, Kidney Int. 26: 752 759.

    PubMed  CAS  Google Scholar 

  270. Lemann J. Jr., Gray, W., Maierhofer, W. J., and Chiung, H. S., 1985, Hydrochlorothiazide inhibits bone resorption in men despite experimentally elevated serum 1,25-dihydroxy vitamin D concentrations, Kidney Int. 28: 951 958.

    PubMed  CAS  Google Scholar 

  271. Lemann, J. Jr., Adams, N. D., and Gray, R. W., 1979, Urinary calcium excretion in human beings, N. Engl. J. Med. 301: 535 541.

    PubMed  CAS  Google Scholar 

  272. Sutton, R. A. L. and Walker, V. R., 1981, Relationship of urinary calcium to sodium excretion in calcareous renal stoneformers: Effect of furosemide, in: Urolithiasis: Clinical and Basic Research ( L. H. Smith, W. G. Robertson, and B. Finlayson, eds.), Plenum Press, New York, pp. 61 66.

    Google Scholar 

  273. Muldowney, F. P., Freaney, R., and Moloney, M. F., 1982, Importance of dietary sodium in the hypercalciuria syndrome, Kidney Int. 2: 292 296.

    Google Scholar 

  274. Silver, J., Friedlaendcr, M. M., Rubinger, D., and Popovtzer, M. M., 1983, Sodium-dependent idiopathic hypercalciuria in renal stoneformers, Lancet 2: 484 486.

    PubMed  CAS  Google Scholar 

  275. Aladjem, M., Modan, M., Lusky, A., Georgi, R., Orda, S., Eshkol, A., Lotan, D., and Boichis, H., 1983, Idiopathic hypercalciuria: A familiar generalized renal hyperexcretory state, Kidney Int. 24: 549 554.

    PubMed  CAS  Google Scholar 

  276. Breslau, N. A., McGuire, J. L., Zerwekh, J. E., and Pak, C. Y. C., 1982, The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism, J. Clin. Endocr. Metab. 55: 369 373.

    PubMed  CAS  Google Scholar 

  277. Lemann, J. Jr., Gray, R. W., Maierhofer, W. J., and Cheung, H. S., 1986, The importance of renal net acid excretion as a determinant of fasting urinary calcium excretion, Kidney Int. 29: 743 746.

    PubMed  CAS  Google Scholar 

  278. Menon, M. and Mahle, C. J., 1983, Urinary citrate excretion in patients with renal calculi, J. Urol. 129: 1158 1160.

    PubMed  CAS  Google Scholar 

  279. Schwille, P. O., Scholz, D., Schwille, K., Leutschaf, T. R., Goldberg, I., and Sigel, A., 1982, Citrate in urine and serum and associated variable in subgroups of urolithiasis. Results from an outpatient stone clinic, Nephron 31: 194 202.

    PubMed  CAS  Google Scholar 

  280. Nicar, M. J., Skural, C., Sakhaee, K., and Pak, C. Y. C., 1983, Low urinary citrate excretion in nephrolithiasis, Urology 21: 8 14.

    PubMed  CAS  Google Scholar 

  281. Jenkins, A. D., Dousa, T. P., and Smith, L. H., 1985, Transport of citrate across renal brush border membrane: Effects of dietary acid and alkaline loading, Am. J. Physiol. 249: F590 F595.

    PubMed  CAS  Google Scholar 

  282. Simpson, D. P., 1982, Citrate excretion: A window on renal metabolism, Am. J. Physiol. 244: F223 F234.

    Google Scholar 

  283. Pak, C. Y. C., Skural, C., Brinkley, L. and Sakhaee, K., 1984, Augmentation of renal citrate excretion by oral potassium citrate administration, time course, dose, frequency schedule and dose response relationships, J. Clin. Pharmacol. 24: 19 26.

    PubMed  CAS  Google Scholar 

  284. Sakhaee, K., Nicar, M., Hill, K., and Pak, C. Y. C., 1983, Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone forming salts, Kidney Int. 24: 348 352.

    PubMed  CAS  Google Scholar 

  285. Pak, C. Y. C., Peterson, R., Sakhaee, K., Fuller, C., Preminger, G., and Reisch, J., 1985, Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide unresponsive hypercalciuric nephrolithiasis, Am. J. Med. 134: 11 19.

    CAS  Google Scholar 

  286. Preminger, G., Sakhaee, K., Skurla, C., and Pak, C. Y. C., 1985, Prevention of recurrent calcium stoneformation with potassium citrate therapy in patients with distal renal tubular acidosis, J. Urol. 134: 20 23.

    PubMed  CAS  Google Scholar 

  287. Pak, C. Y. C. and Fuller, C., 1986, Idiopathic hypocitraturic calcium oxalate nephrolithiasis successfully treated with potassium citrate, Ann. Intern. Med. 104: 33 37.

    PubMed  CAS  Google Scholar 

  288. Pak, C. Y. C., Fuller, C., Sakhaee, K., Preminger, G. M., and Britton, F., 1985, Long-term treatment of calcium nephrolithiasis with potassium citrate, J. Urol. 134: 11 19.

    PubMed  CAS  Google Scholar 

  289. Kitamura, T., Zerwekh, J. E., and Pak, C. Y. C., 1982, Partial biochemical and psychiochemical characterization of organic macromolecules in urine from patients with renal stones and control subjects, Kidney Int. 21: 379 386.

    PubMed  CAS  Google Scholar 

  290. Ito, H. and Coe, F. L., 1977, Acidic peptide and polyribonucleotide crystal growth inhibitors in human urine, Am. J. Physiol. 233: F455 F463.

    PubMed  CAS  Google Scholar 

  291. Nakagawa, Y., Abram, B., Parks, J. H., Lau, H. S. S., Kawooya, J. K., and Coe, F. L., 1985, Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis, J. Clin. Invest. 76: 1455 1462.

    PubMed  CAS  Google Scholar 

  292. Liu, S. H. and Chu, E., 1943, Studies of calcium and phosphorus metabolism with special reference to pathogenesis and effects of dihydro tachysterol (A.T. 10) and iron, Medicine 22: 103 161.

    CAS  Google Scholar 

  293. Stanbury, S W., 1957, Azotemic renal osteodystrophy, Br. Med. Bull. 13: 57 60.

    PubMed  CAS  Google Scholar 

  294. Hodgson, S. F., 1986, Skeletal remodeling and renal osteodystrophy, Semin. Nephrol. 6: 42 55.

    PubMed  CAS  Google Scholar 

  295. Ott, S. M., Maloney, N. A., Coburn, J. W., Alfrey, A. C., and Sherrard, D. J., 1982, The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy, N. Engl. J. Med. 307: 709 713.

    PubMed  CAS  Google Scholar 

  296. Llach, F., Felsenfeld, A. J., Coleman, M. D., Keveney, J J. Jr., Pederson, J., and Medlock, R. J., 1986, The natural courses of dialysis osteomalacia, Kidney Int. 29 (S18): S74 S79.

    Google Scholar 

  297. Chan, Y-L., Furlong, T. J., Cornish, C. J., and Posen, S., 1985, Dialysis osteodystrophy, Medicine 64: 296 308.

    PubMed  CAS  Google Scholar 

  298. Sherrard, D. J., 1986, Renal osteodystrophy, Semin. Nephrol. 6: 56 67.

    PubMed  CAS  Google Scholar 

  299. Savory, J. and Wills, M. R., 1986, Methods of aluminum measurement, Kidney Int. 29 (S18): S24 S27.

    Google Scholar 

  300. Malluche, M. H., Faugere, M-C., Smith, A. J., Jr., and Friedler, R. H., 1986, Aluminum intoxication of bone in renal failure—Fact or fiction, Kidney Int. 29 (S18): S70 S73.

    Google Scholar 

  301. Coburn, J. W. and Slatopolsky, E., 1986, Vitamin D, parathyroid hormone, and renal osteodystrophy, in: The Kidney ( B. M. Brenner and F. C Rector, eds.), Saunders, Philadelphia, pp. 1657 1729.

    Google Scholar 

  302. Wilson, L., Felsenfeld, A., Drezner, M. K., and Llach, F., 1985, Altered divalent ion metabolism in early renal failure: Role of l,25(OH)2D, Kidney Int. 27: 565 573.

    PubMed  CAS  Google Scholar 

  303. Johnson, W. J., 1986, Use of vitamin D analogues in renal osteodystrophy, Semin Neprhol. 6:31-41.

    Google Scholar 

  304. Dunstan, C. R. and Evans, R. A., 1986, Aluminum and renal bone disease in Australia, Kidney Int. 29 (S18): S65 S69.

    Google Scholar 

  305. McCarthy, J. T. and Kumar, R., 1986, Behavior of the vitamin D endocrine system in the development of renal osteodystrophy, Semin. Nephrol. 6: 21 30.

    PubMed  CAS  Google Scholar 

  306. Shany, S., Rapoport, J., Zuili, I., Yankowitz, N., and Chaimovitz, C., 1986, Enhancement of 24,25-dihydroxyvitamin D levels in patients with continuous ambulatory peritoneal dialysis, Nephron 42: 141 145.

    PubMed  CAS  Google Scholar 

  307. Hodsman, A. B., Wong, E. G. C., Sherrard, D. J., Brickman, A. S., Lee, D. B. N., Singer, F. R., Norman, A. W., and Coburn, J. W., 1983, Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalacia, Am. J. Med. 73: 407 414.

    Google Scholar 

  308. Heaf, J. G., Pødenphant, J., and Andersen, J. R., 1986, Bone aluminum deposition in maintenance dialysis patients treated with aluminum-free dialysate: Role of aluminum hydroxide consumption, Nephron 42: 210 216.

    PubMed  CAS  Google Scholar 

  309. Cournot-Witmer, G., Plachot, J.-J., Bourdeau, A., Lieberherr, M., Jorgetti, V., Mendes, V., Halpern, S., Hemmerle, J., Drüeke, T., and Balsan, S., 1986, Effect of aluminum on bone and cell localization, Kidney Int. 29 (S18): S37 S40.

    Google Scholar 

  310. de Vernejoul, M. C., Belenguer, R., Halkidou, H., Buisine, A., Bielakoff, J., and Miravet, L., 1985, Histomorphometric evidence of deleterious effect of aluminum on osteoblasts, Bone 6: 15 20.

    PubMed  Google Scholar 

  311. Morrissey, J. and Slatopolsky, E., 1986, Effect of aluminum on parathyroid hormone secretion, Kidney Int. 29 (S18): S41 S44.

    Google Scholar 

  312. de Vernejoul, M. C., Marchais, S., London, G., Morieux, C., Bielakoff, J., and Miravet, L., 1985, Increased aluminum deposition after subtotal parathyroidectomy in dialyzed patients, Kidney Int. 27: 785 791.

    PubMed  Google Scholar 

  313. Ott, S., Andress, L., Nebeker, H. G., Milliner, D. S., Maloney, N. A., Coburn, J. W., and Sherrard, D. J., 1986, Changes in bone histology after treatment with desferrioxamine, Kidney Int. 29 (S18):S 108 S113.

    Google Scholar 

  314. Kerr, D. N. S., Ward, M. K., Arze, R. S., Ramos, J. M., Grekas, D., Parkinson, I. S., Ellis, H. A., Owen, J. P., Simpson, W., Dewar, J., Martin, A. M., and McHugh, M. F., 1986, Aluminum-induced dialysis osteodystrophy: The demise of “Newcastle bone disease”? Kidney Int. 29 (S18): S58 S64.

    Google Scholar 

  315. Prior, J. C., Cameron, E. C., Knickerbocker, W. J., Sweeny, V. P., and Suchowersky, O., 1982, Dialysis encephalopathy and osteomalacic bone disease. A case-controlled study, Am. J. Med. 72: 33 42.

    PubMed  CAS  Google Scholar 

  316. Ihle, B. U., Becker, G. J., and Kincaid-Smith, P. S., 1986, Clinical and biochemical features of aluminum related bone disease, Kidney Int. 29 (S18): S80 S86.

    Google Scholar 

  317. Malluche, H. H., Faugere, M-C., Fanti, P., and Price, P. A., 1984, Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis, Kidney Int. 26: 869 874.

    PubMed  CAS  Google Scholar 

  318. Coen, G., Mazzaferro, S., Bonucci, E., Taggi, F., Ballanti, P., Bianchi, A. R., Donato, G., Massimetti, C., Smacchi, A., and Cinotti, G. A., 1985, Bone GLA protein in predialysis chronic renal failure. Effects of l,25(OH)2D3 administration in long term follow up, Kidney Int. 28: 783 790.

    Google Scholar 

  319. Netter, P., Kessler, M., Burnel, D., Hutin, M.-F., Delones, S., Benoit, J., and Baucher, A., 1984, Aluminum in the joint tissues of chronic renal failure patients treated with regular hemodialysis and aluminum compounds, Rheumatology 11: 66 70.

    CAS  Google Scholar 

  320. Milliner, D. S., Hercz, G., Miller, J. H., Shinaberger, J. H., Nissenson, A. R., and Coburn, J. W., 1986, Clearance of aluminum by hemodialysis: Effect of desferrioxamine, Kidney Int. 29 (S18): S100 S103.

    Google Scholar 

  321. Nebeker, H. G., Andress, D. L., Milliner, D. S., Ott, S. M., Alfrey, A. C., Slatopolsky, E. A., Sherrard, D.J., and Coburn, J. W., 1986, Indirect meth ods for the diagnosis of aluminum bone disease: Plasma aluminum, the desferrioxamine infusion test and serum PTH, Kidney Int. 29 (S18): S96 S99.

    Google Scholar 

  322. Malluche, H. H., Smith, A. J., Abreo, K., and Faugere, M. C., 1984, The use of desferrioxamine in the management of aluminum accumulation in bone in patients with renal failure, N. Engl. J. Med. 311: 140 144.

    PubMed  CAS  Google Scholar 

  323. Hodsman, A. B., Hood, S. A., Brown, P., and Cordy, P. E., 1985, Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before and after chelation by desferrioxamine? J. Lab. Clin. Med. 106: 674 681.

    PubMed  CAS  Google Scholar 

  324. Letteri, J. M., 1984, Treatment of renal osteodystrophy in chronic renal failure, in: Nephrology, Volume II ( R. R. Robinson, ed.), Springer-Verlag, New York, pp. 1396 1405.

    Google Scholar 

  325. Campese, V., Easterling, R. E., Finkelstein, F., Mattern, W., Ogden, D. A., Steiner, R. W., and Orepoulos, D. G., 1984, Renal osteodystrophy and the status of aluminum and other trace metals in CAPD patients: A panel review, Peritoneal Dialysis Bull. 4: 129 136.

    Google Scholar 

  326. Santos, F., Massie, M D., and Chan, J. C. M., 1986, Risk factors in aluminum toxicity in children with chronic renal failure, Nephron 42: 189 195.

    PubMed  CAS  Google Scholar 

  327. Burt, H. M., Cameron, E. C., Leung, M., Erber, H., and Price, J. D. E., 1986, In vitro studies using ion exchange resins as potential phosphate binders for renal failure patients, Uremia Invest. 9: 35 44.

    CAS  Google Scholar 

  328. Fournier, A., Moriniere, P., Sebert, J. L., Dkhissi, H., Atik, A., Leflon, P., Renaud, H., Gueris, J., Gregoire, I., Idrissi, A., and Garabedian, M., 1986, Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia, Kidney Int. 29 (S18): S114 S119.

    Google Scholar 

  329. Schneider, H. W., Kulbe, K. D., Weber, H., and Streicher E., 1986, In vitro and in vivo studies with non-aluminum phosphate-binding compound, Kidney Int. 29 (S18): S120 S123.

    Google Scholar 

  330. Felsenfeld, A. J., Gutman, R. A., Llach, F., Harrelson, J. M., and Wells, S. A., 1984, Postparathyroidectomy hypocalcemia as an accurate indicator of preparathyroidectomy bone histology in the uremic patient, Miner. Electrolyte Metab. 10: 166 172.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada, V5Z 1M9

    Roger A. L. Sutton & E. C. Cameron

Authors
  1. Roger A. L. Sutton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. C. Cameron
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Washington University School of Medicine, St. Louis, Missouri, USA

    Saulo Klahr M.D.

  2. University of Southern California School of Medicine, Los Angeles, California, USA

    Shaul G. Massry M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Plenum Publishing Corporation

About this chapter

Cite this chapter

Sutton, R.A.L., Cameron, E.C. (1987). Mineral Metabolism. In: Klahr, S., Massry, S.G. (eds) Contemporary Nephrology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1859-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1859-0_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9037-7

  • Online ISBN: 978-1-4613-1859-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation